Spots Global Cancer Trial Database for farnesyl protein transferase inhibitor
Every month we try and update this database with for farnesyl protein transferase inhibitor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients With Leukemia (Study P00701) | NCT00034684 | Leukemia Myelodysplastic... Leukemia, Myelo... Blast Crisis Leukemia, Lymph... | Farnesyl Protei... | 18 Years - | Merck Sharp & Dohme LLC | |
| Safety and Tolerability Study of Farnesyl Protein Transferase Inhibitor in Combination With Gemcitabine and Cisplatin in Advanced Cancer (Study P01499)(TERMINATED) | NCT00040534 | Neoplasms | Farnesyl Protei... | 18 Years - | Merck Sharp & Dohme LLC | |
| Farnesyl Protein Transferase Inhibitor (FPTI) in Combination With Docetaxel in Advanced Solid Tumors (Study P01964)(COMPLETED) | NCT00040547 | Neoplasms | Farnesyl Protei... | 18 Years - 65 Years | Merck Sharp & Dohme LLC | |
| Safety and Tolerability Study of Farnesyl Protein Transferase Inhibitor in Combination With Gemcitabine and Cisplatin in Advanced Cancer (Study P01499)(TERMINATED) | NCT00040534 | Neoplasms | Farnesyl Protei... | 18 Years - | Merck Sharp & Dohme LLC |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
